Free Trial

Eurofins Scient (OTCMKTS:ERFSF) Shares Gap Down - Should You Sell?

Eurofins Scient logo with Medical background

Key Points

  • Eurofins Scient's shares gapped down from a previous close of $75.72 to $73.83 at market opening, with trading volume reported at 200 shares.
  • Wall Street analysts maintain a cautious outlook, with Citigroup reaffirming a "neutral" rating and an average stock rating of "Hold."
  • The company's debt-to-equity ratio stands at 0.77, with a current ratio of 1.26 and a quick ratio of 1.19.
  • Interested in EUROFINS SCIENT? Here are five stocks we like better.

Eurofins Scient (OTCMKTS:ERFSF - Get Free Report)'s share price gapped down before the market opened on Tuesday . The stock had previously closed at $75.72, but opened at $73.83. Eurofins Scient shares last traded at $73.83, with a volume of 200 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Citigroup reaffirmed a "neutral" rating on shares of Eurofins Scient in a report on Friday, July 25th. One equities research analyst has rated the stock with a Strong Buy rating and five have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold".

View Our Latest Report on ERFSF

Eurofins Scient Trading Down 3.8%

The business's fifty day moving average price is $75.91 and its 200-day moving average price is $66.59. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.26 and a quick ratio of 1.19.

Eurofins Scient Company Profile

(Get Free Report)

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in EUROFINS SCIENT Right Now?

Before you consider EUROFINS SCIENT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EUROFINS SCIENT wasn't on the list.

While EUROFINS SCIENT currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.